首页> 外文期刊>New Microbes and New Infections >First description of a cefixime- and ciprofloxacin-resistant Neisseria gonorrhoeae isolate with mutations in key antimicrobial susceptibility–determining genes from the country of Georgia
【24h】

First description of a cefixime- and ciprofloxacin-resistant Neisseria gonorrhoeae isolate with mutations in key antimicrobial susceptibility–determining genes from the country of Georgia

机译:首次对耐头孢克肟和环丙沙星的淋病奈瑟氏球菌分离株进行了描述,这些分离株的关键抗菌药敏感性决定基因来自佐治亚州

获取原文
           

摘要

Antimicrobial resistance in Neisseria gonorrhoeae is a global health problem. Enhanced international collaborative surveillance and disease control are needed to reduce the global burden of this important pathogen. Currently the antimicrobial resistance properties and molecular mechanisms of multidrug-resistant N.?gonorrhoeae in the Republic of Georgia represent a significant knowledge gap. Here we report the isolation of a strain of N.?gonorrhoeae exhibiting resistance to cefixime and ciprofloxacin with reduced susceptibility to penicillin and tetracycline from a patient being treated at a Georgian medical centre. Notably, this isolate was found to contain a mosaic penA allele and to harbour mutations in genes conferring susceptibility to the β-lactam, cephalosporin, fluoroquinolone, macrolide and penicillin classes of antibiotic. To our knowledge, this is the first report to describe the key mutations conferring the antimicrobial resistance properties of an isolate of N.?gonorrhoeae from Georgia.
机译:淋病奈瑟菌的抗药性是一个全球性的健康问题。需要加强国际协作监测和疾病控制,以减轻这种重要病原体的全球负担。目前,佐治亚共和国的耐多药性淋病奈瑟氏球菌的耐药性和分子机制表现出巨大的知识差距。在这里,我们从格鲁吉亚医学中心接受治疗的患者中分离出一株对头孢克肟和环丙沙星具有耐药性且对青霉素和四环素的敏感性降低的淋球菌。值得注意的是,发现该分离物含有镶嵌penA等位基因,并且在赋予对β-内酰胺,头孢菌素,氟喹诺酮,大环内酯和青霉素类抗生素敏感的基因中带有突变。据我们所知,这是第一份描述赋予佐治亚州淋病奈瑟菌分离物抗药性的关键突变的报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号